EFFERALGAN 150 mg, suppository 10 suppositories
Brand page: Doliprane, Dafalgan, Efferalgan (paracetamol) — all forms and strengths in France
Active ingredients: Paracetamol
Commercialized according to BDPM
Suppository10 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EFFERALGAN 150 mg, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène de 10 suppositoire(s)
- Marketing authorisation holder
- UPSA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1995
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64675665CIP73390579CIP133400933905798Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PARACÉTAMOLsuppositoire | 150 mg · un suppositoire | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.